Celldex Therapeutics, Inc CLDX
$38.71
+0.52%
at last close
Market Cap$3.02 billion
P/E Ratio—
Div Yield—
Volume1.00M
52-Week Range
$20.37$45.14
Analyst Ratings
- Consensus
- Buy — 10 Buy · 1 Hold · 0 Sell (11 analysts)
- Avg. Price Target
- $57.55 (+48.7% upside)
Key Stats
- Today's Range
- $38.25 – $39.21
- 50-Day Range
- $33.37 – $45.14
- 52-Week Range
- $20.37 – $45.14
- Volume
- 1.00 million shs
- Average Volume
- 763K shs
- Market Cap
- $3.02 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 9.28%
- Days to Cover
- 6.86
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Related Stocks
Compare head-to-head: CLDX vs IDXX·CLDX vs LNTH·CLDX vs NTLA·CLDX vs QDEL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.